home / stock / ktov / ktov news

KTOV News and Press, Kitov Pharma Ltd. From 10/02/19

Stock Information
Company Name: Kitov Pharma Ltd.
Stock Symbol: KTOV
Market: NASDAQ
Menu
KTOV KTOV Quote KTOV Short KTOV News KTOV Articles KTOV Message Board
Get KTOV Alerts

News, Short Squeeze, Breakout and More Instantly...
KTOV - Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board

Appointment of industry leader brings broad R&D Oncology Experience to Board TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) --   Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor i...
KTOV - Kitov Pharma: NT-219 Data Reveals Ability To Reverse Pancreatic Cancer Drugs Resistance And The Market Doesn't Care

On September 9th, Kitov Pharma ( KTOV ) presented proof-of-concept data displaying NT-219’s mechanism of action in reversing cancer drug resistance in pre-clinical models. NT-219 is a “first-in-class small molecule bi-specific inhibitor” of STAT3 and IRS1/2. Previously, ...

KTOV - Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance

Data validates NT-219 mechanism of action in reversing resistance to various FDA-approved treatments in pancreatic tumor models of mice implanted with biopsies from patients (PDX) NT-219’s novel mechanism of action may open new avenues for combination therapies with targ...

KTOV - Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

TEL AVIV, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that Isaac Israel, CEO, and Gil Efron, Depu...
KTOV - Key events next week - healthcare

Noteworthy events during the week of September 1 - 9 for healthcare investors. More news on: Synlogic, Inc., Orchard Therapeutics plc, Zosano Pharma Corporation, Healthcare stocks news, , Read more ...

KTOV - Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Science and Clinical Care Conference

TEL AVIV, Israel, Aug. 29, 2019 (GLOBE NEWSWIRE) --   Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that Kitov’s subsidiary, TyrN...

KTOV - Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal

- Orbimed, Pontifax and Arkin Holdings to deposit $3.5 million investment in Kitov in escrow - Progress facilitates the advance of activities in development of the oncology asset CM-24 TEL AVIV, Israel, Aug. 16, 2019 (GLOBE NEWSWIRE) --   Kitov Pharma Ltd. (“Kitovȁ...
KTOV - Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority

Israeli Investigation of Kitov and certain officers has been terminated TEL AVIV, Israel, Aug. 14, 2019 (GLOBE NEWSWIRE) --   Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion ...

KTOV - Kitov Pharma reports 1H results

Kitov Pharma (NASDAQ: KTOV ): 1H GAAP EPS of -$0.14. More news on: Kitov Pharma Ltd, Earnings news and commentary, Healthcare stocks news, , Read more ...

KTOV - Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update

TEL AVIV, Israel, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced financial results for the six-month period end...
Previous 10 Next 10